Dear Thomas,
for me the link to the doodle is currently not working.
Any idea what might be wrong ?
Best regards,
Ivo
On 20/04/2011 10:30, Thomas Giger wrote:
Dear All,
I have added more days in the first week of May (3-6) for scheduling
the TC.
Can I ask you to update the data that you have already entered in the
doodle?
Could you please fill in the doodle by Monday (April 25)?
here's the link:
http://doodle.com/cnfc85cx9ushxzyb
cheers,
Thomas
On Apr 19, 2011, at 12:31 PM, Emmanouil Dermitzakis wrote:
Hi Ivo and all
I agree!
We have to do this soon though so I will ask Thomas to add more dates
the week after but we should not slide beyond it.
Cheers
Manolis
MD
Sent from my iPhone
Please excuse typos/brevity
On Apr 19, 2011, at 11:36 AM, Ivo Gut <igut(a)pcb.ub.es
<mailto:igut@pcb.ub.es>> wrote:
Dear All,
unfortunately for you, I am on holidays next week. I was in the call
yesterday and I think it is critical that we nail this experiment
down absolutely right, otherwise we will certainly fail. This
experiment is too expensive for us to fail !!!
Any chance of suggesting other dates ?
With best regards,
Ivo
On 19/04/2011 10:42, Thomas Giger wrote:
Dear All,
As we decided yesterday, the people involved in the RNAseq related
part of the experiment should have a conference call to discuss
open questions.
I have written down the following points that should be discussed:
1. As of now we made plans that the different labs analyze samples
from one particular population (as listed in the workflow document
that I've sent around on April 7).
It would be a better experimental design if the samples were
randomly distributed among the different labs. Since there is still
time to react - do we want to switch the strategy?
2. How long are the library prep / sequencer queue up times in the
different labs (once you receive the RNA samples - how long do you
think will it take you to analyze them?).
If some labs expect to have much larger delays, we could make
arrangements that those labs get samples earlier than other labs.
This would also mean that we would all use the protocol that is
used at the time point when the first lab starts to analyze samples.
3. Which other samples (other than the 500 1KGP European samples)
should be analyzed by RNAseq?
4. Specifications for the small RNA protocol.
If you know already now, that you would like to have additional
things discussed - please let me know and I can make sure that we
don't forget about.
We would like to schedule the call for either next Tuesday (April
26) or Wednesday (April 27).
Please fill in the doodle by the end of this week so that we can
select a time where a maximum number of people can attend the call:
http://doodle.com/cnfc85cx9ushxzyb
cheers,
Thomas
------------------------------------------------------------------------
Thomas Giger, Ph.D.
Department of Genetic Medicine and Development
University of Geneva Medical School
1 Rue Michel-Servet
Geneva 1211
Switzerland
_______________________________________________
Geuvadis_rnaseq mailing list
Geuvadis_rnaseq(a)lists.crg.es <mailto:Geuvadis_rnaseq@lists.crg.es>
http://davinci.crg.es/mailman/listinfo/geuvadis_rnaseq
_______________________________________________
Geuvadis_rnaseq mailing list
Geuvadis_rnaseq(a)lists.crg.es <mailto:Geuvadis_rnaseq@lists.crg.es>
http://davinci.crg.es/mailman/listinfo/geuvadis_rnaseq
_______________________________________________
Geuvadis_rnaseq mailing list
Geuvadis_rnaseq(a)lists.crg.es <mailto:Geuvadis_rnaseq@lists.crg.es>
http://davinci.crg.es/mailman/listinfo/geuvadis_rnaseq
------------------------------------------------------------------------
Thomas Giger, Ph.D.
Department of Genetic Medicine and Development
University of Geneva Medical School
1 Rue Michel-Servet
Geneva 1211
Switzerland